Brought to you by 
Medtronic to buy Kyphon for cash
02 Aug 2007
Executive Summary
Medtronic has agreed to acquire all the outstanding shares of minimally invasive spinal device maker Kyphon for $71 each (a 30% premium). The deal price of $3.9bn consists of $3.56bn in equity, which includes $700mm that Medtronic will spend to buy shares under stock options that have vested, and $350mm in debt.
Deal Industry
- Medical Devices
-
Medical Devices
- Implantable Devices
-
Surgical Equipment & Devices
- Minimally or Less Invasive
Deal Status
- Final
Deal Type
-
Acquisition
- Full Acquisition
- Includes Contract
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Medtronic to buy Kyphon for cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice